Brentuximab (Anti-TNFRSF8 / CD30)
Brentuximab (Anti-TNFRSF8 / CD30) is a chimeric monoclonal antibody targeting anti-CD30 with antineoplastic activity. It has the potential to alter the disease course of non-MF/SS CTCLs. MW : 145.38 KD.
| Catalog Number | A2322 |
| CAS# | 2088770-90-3 |
| Size | 1mg |
| Supplier Page | http://www.selleckchem.com/products/brentuximab-anti-tnfrsf8-cd30.html |